Two Sigma Securities’s China Pharma Holdings CPHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.5K | Buy |
+35,666
| New | +$24.9K | ﹤0.01% | 1471 |
|
|
2025
Q2 | – | Sell |
-2,534
| Closed | -$6.67K | – | 1592 |
|
|
2025
Q1 | $6.67K | Sell |
2,534
-4,449
| -64% | -$10.2K | ﹤0.01% | 1278 |
|
|
2024
Q4 | $16.2K | Buy |
6,983
+5,078
| +267% | +$11K | ﹤0.01% | 1352 |
|
|
2024
Q3 | $4.5K | Buy |
+1,905
| New | +$4.2K | ﹤0.01% | 2675 |
|
|
2024
Q2 | – | Sell |
-1,428
| Closed | -$5.3K | – | 3077 |
|
|
2024
Q1 | $5.3K | Buy |
+1,428
| New | +$6.28K | ﹤0.01% | 2831 |
|
|
2023
Q4 | – | Sell |
-1,217
| Closed | -$9.01K | – | 3105 |
|
|
2023
Q3 | $9.01K | Buy |
1,217
+833
| +217% | +$10.1K | ﹤0.01% | 2710 |
|
|
2023
Q2 | $6.55K | Buy |
+384
| New | +$6.75K | ﹤0.01% | 2645 |
|
|
2023
Q1 | – | Sell |
-118
| Closed | -$5.64K | – | 2752 |
|
|
2022
Q4 | $5.64K | Buy |
118
+77
| +188% | +$4.7K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $3K | Buy |
+41
| New | +$4.04K | ﹤0.01% | 2501 |
|
|
2022
Q2 | – | Sell |
-27
| Closed | -$5K | – | 2300 |
|
|
2022
Q1 | $5K | Buy |
+27
| New | +$5.64K | ﹤0.01% | 2062 |
|
|
2021
Q1 | – | Sell |
-69
| Closed | -$15K | – | 998 |
|
|
2020
Q4 | $15K | Buy |
+69
| New | +$14.8K | ﹤0.01% | 1612 |
|
|
2020
Q3 | – | Sell |
-24
| Closed | -$8K | – | 1350 |
|
|
2020
Q2 | $8K | Buy |
+24
| New | +$5.92K | ﹤0.01% | 1318 |
|
|
2019
Q4 | – | Sell |
-21
| Closed | -$3K | – | 2370 |
|
|
2019
Q3 | $3K | Buy |
+21
| New | +$2.87K | ﹤0.01% | 2013 |
|
|
2019
Q1 | – | Sell |
-70
| Closed | -$9K | – | 1904 |
|
|
2018
Q4 | $9K | Buy |
70
+8
| +13% | +$1.16K | ﹤0.01% | 2024 |
|
|
2018
Q3 | $6K | Buy |
+62
| New | +$7.28K | ﹤0.01% | 2509 |
|
|
2018
Q1 | – | Sell |
-27
| Closed | -$2K | – | 2694 |
|
|
2017
Q4 | $2K | Buy |
+27
| New | +$2.34K | ﹤0.01% | 1699 |
|
Other funds holding CPHI
GSC
EI
DB
Two Sigma Securities's CPHI Position: Q2 2026 in Review
Two Sigma Securities opened a new position in China Pharma Holdings (CPHI) in Q2 2026: 35,666 shares worth $23.5K. The stake represents ﹤0.01% of the portfolio and ranks #1471 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in CPHI as recently as Q1 2025.
Two Sigma Securities first reported a position in CPHI in Q4 2017 and has held it in 16 quarters since. 8 funds tracked by Wall St. Rank hold CPHI as of Q2 2026.
- Two Sigma Securities held 35,666 shares of China Pharma Holdings worth $23.5K as of Q2 2026.
- China Pharma Holdings was a new Two Sigma Securities position in Q2 2026.
- China Pharma Holdings made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1471 holding.
- Two Sigma Securities first reported a position in China Pharma Holdings in Q4 2017 and has held it in 16 quarters since.
- 8 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.